We have developed the world’s first and market-leading organ-on-chip platform, powered by pharmaceutical-scale engineering and advanced image-based AI. This technology addresses a critical gap in preclinical research by providing physiologically realistic human organ models, enabling more predictive drug discovery while reducing reliance on animal testing.
90% vs. 50-65% with live animals
Engineering
Economical microfluidic chips and perfusion solution that balance complexity and throughput.
Imaging
Multiple cell staining methods and high content imaging analysis to accurately capture 3D morphology.
1-857-431-8286
500 Rutherford Ave, Boston, MA 02129
Leave us a request and we will contact you soon.
